Cita APA (7a ed.)

Tang, T., Wang, G., Liu, S., Zhang, Z., Liu, C., Li, F., . . . Zhao, L. (2021). Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis. Nature Portfolio.

Cita Chicago Style (17a ed.)

Tang, Tiantian, et al. Highly Expressed SLCO1B3 Inhibits the Occurrence and Development of Breast Cancer and Can Be Used as a Clinical Indicator of Prognosis. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Tang, Tiantian, et al. Highly Expressed SLCO1B3 Inhibits the Occurrence and Development of Breast Cancer and Can Be Used as a Clinical Indicator of Prognosis. Nature Portfolio, 2021.